
Jake Kohn
Articles
-
Jan 15, 2025 |
jdsupra.com | Jake Kohn
The Centers for Medicare & Medicaid Services (CMS) has issued the Calendar Year (CY) 2026 Advance Notice, proposing updates to payment policies for Medicare Advantage (MA) and Medicare Part D Prescription Drug Programs. This release builds on the Contract Year 2026 MA and Part D proposed rule from November 2024, continuing CMS’s commitment to fiscally responsible, technical updates aimed at maintaining the stability and affordability of these programs.
-
Jan 9, 2025 |
natlawreview.com | Tom Martin |Jake Kohn |Thomas Kane |Steven T. Passarella
Law firms today face a turning point. Clients demand more efficient, cost-effective services; younger associates are eager to leverage the latest technologies for legal tasks; and partners try to reconcile tradition with agility in a highly competitive marketplace.
-
Jan 9, 2025 |
natlawreview.com | Jake Kohn |Tom Martin |Thomas Kane |Steven T. Passarella
Representative Jay Obernolte (R-Calif.) has emerged as a pivotal figure in shaping the United States’ legislative response to artificial intelligence (AI). With a rare combination of technical expertise and political acumen, Obernolte’s leadership is poised to influence how Congress navigates both the opportunities and risks associated with AI technologies. AI Expertise and Early InfluenceObernolte’s extensive background in AI distinguishes him among his congressional peers.
-
Dec 6, 2024 |
natlawreview.com | Jake Kohn
The Drug Enforcement Administration (DEA) has officially extended the pandemic-era telehealth prescribing flexibilities for controlled substances for an additional year, now set to expire on Dec. 31, 2025. This decision, a significant win for telemedicine advocates, ensures the continuation of the current telehealth prescribing rules without substantive changes.
-
Nov 25, 2024 |
jdsupra.com | Jake Kohn
The Drug Enforcement Administration (DEA) has officially extended the pandemic-era telehealth prescribing flexibilities for controlled substances for an additional year, now set to expire on Dec. 31, 2025. This decision, a significant win for telemedicine advocates, ensures the continuation of the current telehealth prescribing rules without substantive changes.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →